Mirabilis Medica said today it won CE Mark approval in the European Union and FDA investigational device exemption for its Mirabilis System designed to treat uterine fibroids. The Bothell, Wash.-based company’s Mirabilis system is designed to use ultrasound to both provide imaging and ablation during procedures to remove uterine fibroids, the company said. The device […]
Mirabilis Medica brings in $5 million
Uterine fibroid-treating device developer Mirabilis Medica raised $5 million in a new round of debt financing, according to an SEC filing posted today. The company’s Mirabilis system is designed to use ultrasound to both provide imaging and ablation during procedures to remove uterine fibroids, the company said. The device uses low-intensity ultrasound waves to locate fibroids […]
Mirabilis Medica raises $5.2m for uterine fibroid treating device
Uterine fibroid-treating device developer Mirabilis Medica raised $5.2 million in a new round of debt financing, according to an SEC filing posted today. The company’s Mirabilis system is designed to use ultrasound to both provide imaging and ablation during procedures to remove uterine fibroids, the company said. The device uses low-intensity ultrasound waves to locate […]
Mirabilis Medica pulls in $13M Series A round for ultrasound fibroid device
Mirabilis Medica said it raised up to $13 million in a Series A1 round and tapped a new CEO to lead the development of its ultrasound treatment for uterine fibroids.
The Bothell, Wash.-based medical device company said it closed on an initial $7 million round led by GSR Ventures, including $4 million in cash and a $3 million conversion of debt to equity. Charter Life Sciences also participated in the round.
